1. Abshagen, U., Rennekamp, H., Kuhlmann, J.: Pharmacokinetics of 4?-methyldigoxin after pretreatment with spironolactone in man. Naunyn Schmiedeberg's Arch. Pharmacol. Suppl.285, R 1 (1974)
2. Anton, A.H., Sayre, D.F.: A study of the factors effecting the aluminium oxide-trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. exp. Ther.138 360?375 (1962)
3. Ashley, J.J., Brown, B.T., Okita, G.T., Wright, S.E.: The metabolites of cardiac glycosides in human urine. J. biol. Chem.232 315?322 (1958)
4. Brown, P., Brüschweiler, F., Pettit, G.R., Reichstein, T.: Field ionization mass spectrometry. III: cardenolides. Org. Mass. Spectrum5 573?597 (1971)
5. Buck, S.H., Lage, G.L.: Possible mechanism of the prevention of digitoxin toxicity by spironolactone in the mouse. Arch. int. Pharmacodyn.189 192?197 (1971)